2024 annual financial data

Neumora Therapeutics, Inc. 2024 Net margin

Neumora Therapeutics, Inc. 2024 net margin with verified reported values.

Direct answer

Net margin was Not calculable.

Operating income was -263,464,000 USD and net income was -243,787,000 USD.
Operating cash flow was -182,936,000 USD.

Get free Neumora Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-263,464,000 USD
Net income
-243,787,000 USD
Operating cash flow
-182,936,000 USD